Altathera Drug Patent Portfolio

Altathera owns 1 orange book drug protected by 6 US patents Given below is the list of Altathera's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11583216 Method of administering sotalol IV/switch 21 Aug, 2039
Active
US10799138 Method of administering sotalol IV/switch 05 Apr, 2039
Active
US10512620 Method of initiating and escalating sotalol hydrochloride dosing 14 Aug, 2038
Active
US11696902 Method of initiating and escalating sotalol hydrochloride dosing 14 Aug, 2038
Active
US12390431 Method Of Escalating Sotalol Hydrochloride Dosing 14 Aug, 2038
Active
US12403109 Sotalol Hydrochloride Dosing 14 Aug, 2028
Active


Given below is the list of recent legal activities going on the following drug patents of Altathera.

Activity Date Patent Number
Patent litigations
Recordation of Patent Grant Mailed 09 Sep, 2025 US12403109
Patent eGrant Notification 02 Sep, 2025 US12403109
Email Notification 02 Sep, 2025 US12403109
Patent Issue Date Used in PTA Calculation 02 Sep, 2025 US12403109
Recordation of Patent eGrant 02 Sep, 2025 US12403109
Mail Patent eGrant Notification 02 Sep, 2025 US12403109
Recordation of Patent Grant Mailed 26 Aug, 2025 US12390431
Email Notification 21 Aug, 2025 US12403109
Issue Notification Mailed 20 Aug, 2025 US12403109
Patent eGrant Notification 19 Aug, 2025 US12390431
Email Notification 19 Aug, 2025 US12390431
Patent Issue Date Used in PTA Calculation 19 Aug, 2025 US12390431
Mail Patent eGrant Notification 19 Aug, 2025 US12390431
Recordation of Patent eGrant 19 Aug, 2025 US12390431
Dispatch to FDC 11 Aug, 2025 US12403109


Altathera's Family Patents

Altathera drugs have patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click below to unlock the full patent family tree.

Family Patents



Altathera Drug List

Given below is the complete list of Altathera's drugs and the patents protecting them.


1. Sotalol Hydrochloride

Sotalol Hydrochloride is protected by 6 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11583216 Method of administering sotalol IV/switch 21 Aug, 2039
(13 years from now)
Active
US10799138 Method of administering sotalol IV/switch 05 Apr, 2039
(13 years from now)
Active
US10512620 Method of initiating and escalating sotalol hydrochloride dosing 14 Aug, 2038
(12 years from now)
Active
US11696902 Method of initiating and escalating sotalol hydrochloride dosing 14 Aug, 2038
(12 years from now)
Active
US12390431 Method Of Escalating Sotalol Hydrochloride Dosing 14 Aug, 2038
(12 years from now)
Active
US12403109 Sotalol Hydrochloride Dosing 14 Aug, 2028
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sotalol Hydrochloride's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List